Cargando…
Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease
Diabetic kidney disease (DKD) frequently leads to end-stage renal disease and other life-threatening illnesses. The dysregulation of glomerular cell types, including mesangial cells, endothelial cells, and podocytes, appears to play a vital role in the development of DKD. Myeloid-derived suppressor...
Autores principales: | Hsieh, Ching-Chuan, Chang, Cheng-Chih, Hsu, Yung-Chien, Lin, Chun-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655277/ https://www.ncbi.nlm.nih.gov/pubmed/36362050 http://dx.doi.org/10.3390/ijms232113263 |
Ejemplares similares
-
Administration of cytokine-induced myeloid-derived suppressor cells ameliorates renal fibrosis in diabetic mice
por: Hsieh, Ching-Chuan, et al.
Publicado: (2018) -
Cytokine-Induced Myeloid-Derived Suppressor Cells Demonstrate Their Immunoregulatory Functions to Prolong the Survival of Diabetic Mice
por: Li, Tung-Teng, et al.
Publicado: (2023) -
Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
por: Lin, Da-Wei, et al.
Publicado: (2023) -
Therapeutic Potential of Extracts from Macaranga tanarius (MTE) in Diabetic Nephropathy
por: Hsu, Yung-Chien, et al.
Publicado: (2023) -
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
por: Lu, Li-Chun, et al.
Publicado: (2019)